BREAST CYTOPATHOLOGY

Index 175
S
Salivary-gland type tumors,
130–132
Sarcoma, 132–134
differentiated from
metaplastic carcinoma,
127
pleomorphic, 149
spindle cell, 150
Secondary tumors, 138,
139–142. See also
Metastatic cancers
Secretory carcinoma, 116
differentiated from lipid-rich
carcinoma, 107
Signet ring cell carcinoma,
103–105
Silicone implants, leakage from,
as mastitis cause, 18,
29–32
Small cell carcinoma
differentiated from
neuroendocrine
carcinoma, 130
neuroendocrine, 128
pulmonary metastatic, 144,
149
Spherulosis, collagenous,
39–42
clinical features of, 39
cytomorphologic
characteristics of, 39–42
differentiated from adenoid
cystic carcinoma, 39, 40,
41, 42, 118
Spindle cell nodules, reactive,
55
Spindle cell tumors/carcinoma,
125
lipoma, 78
myofibroblastoma, 78–79
sarcoma, 150
Squamous cell carcinoma,
118–119
differential diagnoses of, 18,
118, 124
of the lung, 149
metastatic, 18, 118
Squamous metaplasia
atypical, differentiated from
apocrine carcinoma, 124
in cystic lesions, 127
Stomach cancer, metastatic, 143
Sweat gland tumors, 130–132
Syringoma, chondroid, 75–77
differentiated from primary
amyloid tumors, 53
T
Thyroid cancer, metastatic, 143,
146, 147
Trauma, as fat necrosis/
organizing hematoma
cause, 32
“Triple diagnostic approach,”
1–2, 3, 4, 26
Tuberculosis, 18
Tubular carcinoma, 110–113
clinical features of, 110
columnar cell lesions
associated with, 28
cytomorphologic
characteristics of, 110,
111–113
differential diagnoses of, 60,
63, 113
as “gray zone diagnosis,” 28
U
Urogenital tract cancers, 138
V
Vasovagal reaction, fine-needle
aspiration-related, 5